How do you prepare for a pandemic?
IMI Director Pierre Meulien talks about IMI's reaction to the biggest Ebola outbreak in history and how the world is better prepared for future major epidemics.
Site Search
Site Search
Displaying results 331 - 340 of 893
EUPATI patient expert training course is open for enrolment
Applications are now being accepted for EUPATI's 14-month training course for laypeople on medicines research and development.
Data-driven personalised care for Alzheimer's patients
EU and industry-funded researchers are testing wearable devices, Internet of Things technologies and smartphone apps to transform the lives of people with Alzheimer's disease.
Focus on: Ebola
During the month of October we will be taking a look at some of the results of our Ebola-related research projects.
Two genes singled out as significant in the development of Alzheimer's
The PHAGO project has identified two genes that might have a significant impact on Alzheimers disease development and progression.
Ebola can now be detected in 15 minutes. Here’s how the diagnostics tests work
IMI backed three bedside Ebola detection tests that work quickly with minimal equipment or training.
CHEM21 – a step towards a greener and more efficient pharmaceutical industry
The green manufacture of pharmaceuticals and production-related environmental concerns are high on the EU agenda, with the European Commission issuing the ‘European Union Strategic Approach to Pharmaceuticals in the Environment’ in March 2019. The Commission plans to encourage ...
Diabetes project leads to the world’s first validated human beta cell line
IMI’s IMIDIA project set out to study the function of a certain type of cells found in the pancreas which, when malfunctioning or weak, are thought to cause diabetes. We spoke to three of the researchers involved in the project about one of its biggest achievements: the ...
EBiSC allows researchers to accelerate and expand their work
The European Bank for induced pluripotent Stem Cells (EBiSC) delivered a ground-breaking, sustainable repository of induced pluripotent stem cells (iPSCs), which now provides scientists across Europe with access to over 800 disease-relevant and quality controlled iPSC lines. In ...